Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Green

Showing results (31-40 of 305) with videos related to

Pageof 31
Sort By:
Cancers|May 25, 2024
Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive SubtypeShorouk Makhlouf, Nehal M Atallah, Susanna Polotto, et al.
Histopathology|August 4, 2017
Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptationsRokaya El Ansari, Alan McIntyre, Madeleine L Craze, et al.
Histopathology|February 13, 2023
Combined proliferation and apoptosis index provides better risk stratification in breast cancerAsmaa Ibrahim, Michael S Toss, Nehal M Atallah, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|August 27, 2024
Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast CancerAyat G Lashen, Michael S Toss, Catrin S Rutland, et al.
Journal of Cancer Research and Clinical Oncology|September 19, 2014
The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosisGustav J Ullenhag, Ahmad Al-Attar, Abhik Mukherjee, et al.
Histopathology|October 10, 2019
The role of glutaminase in cancerBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Cancers|July 31, 2020
Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical OutcomeRuth M Parks, Mohammad Albanghali, Binafsha M Syed, et al.
Breast Cancer Research and Treatment|July 13, 2010
MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroupsMohammed A Aleskandarany, Emad A Rakha, R Douglas Macmillan, et al.
Histopathology|May 6, 2020
The prognostic significance of ALDH1A1 expression in early invasive breast cancerMaryam Althobiti, Rokaya El Ansari, Mohammed Aleskandarany, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2017
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patientsNarmeen Ahmad, Aula Ammar, Sarah J Storr, et al.
Pageof 31

Showing results (31-40 of 305) with videos related to

Sort By:
Pageof 31
Cancers|May 25, 2024
Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive SubtypeShorouk Makhlouf, Nehal M Atallah, Susanna Polotto, et al.
Histopathology|August 4, 2017
Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptationsRokaya El Ansari, Alan McIntyre, Madeleine L Craze, et al.
Histopathology|February 13, 2023
Combined proliferation and apoptosis index provides better risk stratification in breast cancerAsmaa Ibrahim, Michael S Toss, Nehal M Atallah, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|August 27, 2024
Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast CancerAyat G Lashen, Michael S Toss, Catrin S Rutland, et al.
Journal of Cancer Research and Clinical Oncology|September 19, 2014
The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosisGustav J Ullenhag, Ahmad Al-Attar, Abhik Mukherjee, et al.
Histopathology|October 10, 2019
The role of glutaminase in cancerBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Cancers|July 31, 2020
Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical OutcomeRuth M Parks, Mohammad Albanghali, Binafsha M Syed, et al.
Breast Cancer Research and Treatment|July 13, 2010
MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroupsMohammed A Aleskandarany, Emad A Rakha, R Douglas Macmillan, et al.
Histopathology|May 6, 2020
The prognostic significance of ALDH1A1 expression in early invasive breast cancerMaryam Althobiti, Rokaya El Ansari, Mohammed Aleskandarany, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2017
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patientsNarmeen Ahmad, Aula Ammar, Sarah J Storr, et al.
Pageof 31